
    
      Subjects will be enrolled in a multicenter longitudinal observational study. Parents and
      patients will provide their Informed Consent to upload their data for population-based
      analyses and optionally to adhere to a patient adherence support program "AUMENTA" designed
      to improve their adherence and, ultimately, clinical outcomes. Adherence data will be
      primarily derived from the easypod™ device combined with physician data entry of outcome
      measures. Data will be collected retrospectively and prospectively. This will allow the
      establishment of adherence profiles and explore the hypothesis that patient adherence support
      programs improve adherence and subsequent clinical outcomes. Collected data will be also
      analyzed in a multinational pooled analysis of comparable national studies.

      Primary Objective:

      -To assess the level of adherence of subjects receiving SAIZEN® via easypod™

      Secondary Objectives:

        -  To describe the impact of adherence on clinical outcomes for subject receiving SAIZEN®
           via easypod™

        -  To identify adherence subject profiling

        -  To asses the impact of adherence on IGF1 (i.e. above, below or within normal ranges)

        -  To assess/describe the impact of Mexico patient support program "AUMENTA"
    
  